Latest Health News
- FDA Approves New Label for Opioid Use Disorder DrugThe FDA has approved a new treatment plan a long-acting injection called Sublocade, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with their treatment.
- FDA Approves New Treatment for Rare Lipid Storage DiseaseThe FDA has approved a new pill for adults with cerebrotendinous xanthomatosis (CTX), a rare genetic disease that makes it hard for the body to handle cholesterol properly.
- Measles Outbreaks in U.S. Are Growing: How to Protect YourselfMeasles cases surge in the United States, led by a significant outbreak in Texas, highlighting the need for increased MMR vaccination as recommended by the CDC.
- FDA OKs First Fast-Acting Insulin Biosimilar for Diabetes The FDA has approved Merilog, a new fast-acting insulin biosimilar for managing blood sugar in people with diabetes, marking the first such biosimilar to receive federal approval.
- Many Athletes With Heart Issues May Be Able to Play AgainNew guidelines recommend that decisions about sports participation for athletes with heart conditions should be made jointly by doctors and athletes, highlighting lower risks than previously understood.
- ‘Dangerous’ Hospital Bed Shortages on Horizon: What to KnowA new report anticipates a hospital bed shortage as soon as 2032. Here’s how that could impact you.
- New Studies Show RSV Vaccine Is Safe During PregnancyA vaccine for pregnant women protected babies from respiratory syncytial virus, the leading cause of infant hospitalization in the United States, giving researchers hope for widespread immunity against the disease.
- FDA Approves New Drug for Rare Joint Tumor The FDA has approved vimseltinib, a new oral drug for a rare, noncancerous tumor of the joints known as tenosynovial giant cell tumor (TGCT). It is intended for adults with symptomatic TGCT when surgery could worsen their condition.
- FDA OKs Vaccine for Mosquito-Borne ChikungunyaThe FDA has approved Vimkunya, a first-of-its-kind shot to prevent the viral disease chikungunya in people 12 and older.
- FDA Approves 5-in-1 Vaccine Against Meningococcal DiseaseThe FDA has approved Penmenvy, a new 5-in-1 shot to protect against meningococcal infections or invasive meningococcal disease (IMD) in people ages 10 to 25 years.
- Yogurt May Help Lower Your Colon Cancer Risk: StudyEating at least two servings of yogurt a week may help protect you from cancer in a particular part of the colon.
- How an Ongoing Erosion of Trust Damages Your Mental HealthDistrust of everything from institutions to people closest to you takes a serious toll on health and happiness. Here’s how to find a way back.
- Semaglutide Shows Promise for Cutting Alcohol UseA clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to people with similar alcohol habits who didn’t take the drug.
- FDA OKs Triple Combo for Advanced Large B-Cell LymphomaThe FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).
- GLP-1 Drugs Again Linked to Blindness RiskPeople with type 2 diabetes taking GLP-1 medicines may experience potentially blinding eye conditions as soon as the day after starting the drugs, and eye doctors are now asking their patients to be vigilant in speaking up about any vision changes while taking them.
- FDA Approves New Treatment for NF1-Related TumorsThe FDA has approved a pill for a rare disorder called neurofibromatosis type 1 (NF1). Mirdametinib, sold under the brand name Gomekli, is for adults and children ages 2 and older who have nerve tumors (plexiform neurofibromas) that cause symptoms and can't be fully removed with surgery.
- How Bad Will It Get? Flu Rates Are Still RisingIt seemed like the flu was on the retreat a month ago. But now, nearly 1 in 3 people getting tested for the flu are hearing back from their health care provider that it’s positive.
- Judge Orders Federal Health Website Information to Be RestoredA federal judge on Tuesday ordered the restoration of webpages and content from government health sites that had recently been taken down in response to President Trump’s executive order on gender.
- Juice Cleanses May Disrupt Gut BacteriaThere’s new evidence that juice cleanses can have negative health consequences — particularly due to a lack of an important kind of fiber.
- FDA OKs New Antibiotic Combo for Serious Abdominal InfectionsThe FDA has approved a new antibiotic combination called Emblaveo to treat serious stomach infections in adults who have few or no other treatment options.
- Obesity Stigma Depends on Where You LivePeople living in areas where obesity is more common may experience less stigma, which could help reduce some of the social and health consequences of being overweight.
- FDA OKs Implantable Treatment for Diabetic Macular EdemaThe FDA has approved a new implantable treatment for adults with diabetic macular edema (DME) after studies showed that it could help maintain vision with as few as two treatments per year.
- Hospitalized for Cannabis? Your Risk of Early Death May Rise People who get hospital-based care for cannabis use disorder have a 2.8-fold greater chance of dying within the next five years than people who were of the same age and otherwise had similar health factors.
- Forever Chemicals Are Everywhere. Here’s How to Stress LessIf you're looking for calm in a toxic world, read advice from scientists who study environmental stress.
- FDA OKs New Wearable Infusion Device for Parkinson’sThe FDA has approved Onapgo, a new wearable device for adults with advanced Parkinson’s disease that gives a steady dose of apomorphine under the skin to help manage movement issues and daily symptom changes.
Recommended